Management of Suspected Life-Threatening Perioperative Anaphylaxis and Risk Factors for Near-Fatal and Fatal Outcomes: A Retrospective Study in China.
epinephrine
perioperative anaphylaxis
perioperative outcomes
risk factors
Journal
Therapeutics and clinical risk management
ISSN: 1176-6336
Titre abrégé: Ther Clin Risk Manag
Pays: New Zealand
ID NLM: 101253281
Informations de publication
Date de publication:
2023
2023
Historique:
received:
21
02
2023
accepted:
28
04
2023
medline:
17
5
2023
pubmed:
17
5
2023
entrez:
16
5
2023
Statut:
epublish
Résumé
Perioperative anaphylaxis (POA) is an acute severe systemic hypersensitivity reaction characterized by life-threatening respiratory and circulatory collapse. In our previous study, we reported the epidemiology of suspected POA in China. In the present study, we aimed to elucidate the management and outcomes of these cases and further verify the risk factors for near-fatal and fatal outcomes. This was a retrospective study of 447 cases of suspected life-threatening POA encountered at 112 tertiary hospitals in mainland China between September 2018 and August 2019. Patient characteristics, symptoms, duration of hypotension, treatments, and clinical outcomes were documented. Bivariate logistic regression was used to identify risk factors for near-fatal and fatal outcomes. Most cases of suspected POA (89.9%) were recognized and treated within 5 min. Epinephrine was administered as the initial treatment in 232 (51.9%) cases. Corticosteroids (26.6%), other vasoactive drugs (18.3%), and bronchodilators (1.6%) were also administered as the initial treatment instead of epinephrine. The initial dosage of epinephrine (median, 35 µg) was insufficient according to the anaphylaxis guidelines. On multivariable analysis, age ≥65 years (odds ratio [OR] 7.48; 95% confidence interval [CI]: 1.33-41.87, Most cases in this study were managed in a timely manner, but the epinephrine application should be optimized according to the guidelines. Age ≥65 years, ASA physical status IV, and long-term hypotension were risk factors for near-fatal and fatal outcomes.
Identifiants
pubmed: 37193306
doi: 10.2147/TCRM.S406515
pii: 406515
pmc: PMC10183184
doi:
Types de publication
Journal Article
Langues
eng
Pagination
383-394Informations de copyright
© 2023 Cai et al.
Déclaration de conflit d'intérêts
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
J Clin Anesth. 2021 Nov;74:110404
pubmed: 34171710
Anesthesiology. 2020 Mar;132(3):461-475
pubmed: 31794513
Br J Anaesth. 2018 Oct;121(4):706-721
pubmed: 30236233
Anesthesiology. 2011 Jul;115(1):111-6
pubmed: 21572319
Lancet. 1977 Feb 26;1(8009):466-9
pubmed: 65572
Anesth Analg. 2020 Jul;131(1):173-186
pubmed: 31880630
J Allergy Clin Immunol. 2011 Mar;127(3):587-93.e1-22
pubmed: 21377030
Clin Mol Allergy. 2015 Jun 22;13(1):11
pubmed: 26101469
Biomed Res Int. 2020 May 12;2020:3214186
pubmed: 32461978
Br J Anaesth. 2019 Jul;123(1):e16-e28
pubmed: 30916015
Int Arch Allergy Immunol. 2017;173(3):171-177
pubmed: 28793302
Anesth Analg. 2008 Feb;106(2):392-403
pubmed: 18227290
Front Pharmacol. 2022 Mar 28;13:845689
pubmed: 35418863
Allergy. 2022 Feb;77(2):357-377
pubmed: 34343358
Br J Anaesth. 2019 Jul;123(1):e38-e49
pubmed: 30916022
Clin Exp Allergy. 2000 Aug;30(8):1144-50
pubmed: 10931122
JAMA. 2017 Oct 10;318(14):1346-1357
pubmed: 28973220
J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1169-1178
pubmed: 28888247
Br J Anaesth. 2022 Jan;128(1):45-54
pubmed: 34742540
Br J Anaesth. 2021 Dec;127(6):890-896
pubmed: 34330411
Anaesthesia. 2009 Feb;64(2):199-211
pubmed: 19143700
Allergy. 2018 Jun;73(6):1322-1330
pubmed: 29318637
J Allergy Clin Immunol. 2017 Aug;140(2):335-348
pubmed: 28780941
Br J Anaesth. 2019 Jul;123(1):e50-e64
pubmed: 31130272
Br J Anaesth. 2019 May;122(5):563-574
pubmed: 30916004
Ann Allergy Asthma Immunol. 2017 Oct;119(4):356-361.e2
pubmed: 28958375
J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):1898-1906.e1
pubmed: 29606638
Br J Anaesth. 2018 Jul;121(1):172-188
pubmed: 29935569
Singapore Med J. 2020 Apr;61(4):200-205
pubmed: 31788702
Br J Anaesth. 2018 Jul;121(1):146-158
pubmed: 29935566
SAGE Open Med Case Rep. 2022 Mar 16;10:2050313X221084843
pubmed: 35320983
Front Immunol. 2019 Oct 18;10:2482
pubmed: 31749797
J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2194-2204.e7
pubmed: 30857939
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD006312
pubmed: 18843712
Intensive Care Med. 2018 Jun;44(6):811-822
pubmed: 29868971
J Allergy Clin Immunol Pract. 2023 Jan;11(1):51-62
pubmed: 36162799
Eur Ann Allergy Clin Immunol. 2017 Sep;49(5):196-207
pubmed: 28884986
Am J Respir Cell Mol Biol. 1995 Nov;13(5):540-6
pubmed: 7576689
Anesthesiology. 2013 Sep;119(3):507-15
pubmed: 23835589